Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Sep 15, 2023; 15(9): 1520-1530
Published online Sep 15, 2023. doi: 10.4251/wjgo.v15.i9.1520
Published online Sep 15, 2023. doi: 10.4251/wjgo.v15.i9.1520
Table 1 MALAT1 overexpression and clinical characteristics in GC patients
Samples | Sample | Clinical implications | Ref. |
61 GC/DM, 50 GC/NDM, 36 C | Plasma, tissue | Staging, Metastasis | Xia et al[38] |
150 GC, 15 peritumoral paraffin-embedded | Tissue | OS, PFS | Li et al[49] |
78 GC, 78 NTAT | Tissue | Staging, LNM | Li et al[52] |
60 GC, 60 NTAT | Tissue | Staging, LNM, Tumor size | Zhang et al[53] |
20 GC, 20 NTAT | Tissue | Metastasis | Chen et al[54] |
70 GC, 70 C | Serum | Staging | Lu et al[39] |
89 GC, 89 NTAT | Tissue | LNM, Tumor size | Yan et al[32] |
64 GC, 64 NTAT, 64 C | Tissue, plasma | Metastasis | Zhu et al[33] |
30 GC, 30 NTAT | Tissue | Vascular invasion, Lymphatic invasion | Esfandi et al[30] |
37 GC, 37 NTAT | Tissue | Staging | Li et al[34] |
30 GC, 30 NTAT | Tissue | OS | Dai et al[35] |
24 GC, 24 NTAT, 24 GC/OXA | Tissue | Chemoresistance | Zhang et al[36] |
- Citation: Batista DMO, da Silva JMC, Gigek CO, Smith MAC, de Assumpção PP, Calcagno DQ. Metastasis-associated lung adenocarcinoma transcript 1 molecular mechanisms in gastric cancer progression. World J Gastrointest Oncol 2023; 15(9): 1520-1530
- URL: https://www.wjgnet.com/1948-5204/full/v15/i9/1520.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i9.1520